Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012 (around 13% of all deaths). It is expected that global cancer cases will rise from 14 million in 2012 to 22 million within the next two decades.1 In Ireland, there are 20,454 new cases of cancer per year. 2
Janssen specializes in the treatment of breast cancer, lung cancer, prostate cancer, blood cancers and bowel cancer. Our ultimate goal is to make cancer a preventable, chronic or curable disease. We will achieve this by delivering extraordinary diagnostic and therapeutic solutions that prolong and improve patients’ lives. Our commitment to address the full continuum of cancer care sets us apart and our expertise in oncology is pushing us towards the next frontier – the era of personalised medicines.
For more information, contact:
The Irish Cancer Society
Janssen in Oncology
Man to Man: Irish Stories of Hope in Prostate Cancer, the storybook is a collection of real-life inspiring stories of hope from men with prostate cancer and is designed to offer hope and support to other men with their diagnosis and promote greater psychological supports for those living with the illness. Developed by Janssen, the pharmaceutical division of Johnson & Johnson, in association with the Irish Cancer Society, the storybook is the result of research with people who have been affected by prostate cancer to find out what type of information would help them on their journey to recovery. The research found that not only do other men with prostate cancer find comfort in hearing a real Irish story, doctors and nurses can also draw on those experiences in order to further improve the treatment journey for others.
“The Prostate Cancer: Living, not Just Surviving report, developed by Janssen EMEA in collaboration with several European prostate cancer patient associations, highlights findings from a pan-European survey of prostate cancer patients, caregivers and healthcare professionals.
The report calls for a greater focus on addressing the quality of life needs of men living with prostate cancer in Europe. The report reveals insights into the emotional, social and physical issues faced by prostate cancer patients, their caregivers and their families and aims to raise awareness of the need to improve quality of life for those affected by the disease.”
Make Blood Cancer Visible
The ‘Make Blood Cancer Visible’ campaign was launched by Janssen, in partnership with the Irish Cancer Society and Multiple Myeloma Ireland, in response to poor public awareness and understanding of blood cancers compared with other cancers. Research conducted in Ireland revealed that only 6% of people stating they had heard about blood cancer and felt they knew a lot about it and only 1% of people recall seeing or hearing about it in the media. Overall, 74% agreed that there are low levels of awareness of this rare disease in Ireland. This lack of awareness can lead to many challenges for patients and their families in terms of accurate diagnosis, and access to support, information and appropriate treatments3. Through this campaign we have been asking those impacted by blood cancer - patients, caregivers, family members, and healthcare professionals - to help make it more visible by sharing personal stories. These stories have been collated into a beautiful collection of personal stories from individuals across Europe affected by blood cancer, including an Irish man living with chronic lymphocytic leukaemia (CLL).
1WHO Cancer Factsheet
Last accessed May 2016
2 National Cancer Registry
http://www.ncri.ie/sites/ncri/files/factsheets/FACTSHEET_all%20cancers_0.pdf (Last accessed May 2016)
3Empathy Research of 1,000 Irish Adults. February 2016.